Study of Soluble CD52 as a Tumor Marker and Indicator of Disease Activity in Chronic Lymphocytic Leukemia
Fatma ElSaid Swadan, Hesham Ahmed Elserogy, Mohamed Attia Saad Attiaa & Hussam ElDin Ahmed ElAshtokhy · Journal of Advances in Medicine and Medical Research · 2022
Background: Chronic Lymphocytic Leukemia (CLL) is non-curable disease and has variable course among patients. In some patients it progresses fast despite sever treatment and is fatal within 2 to 3 years whereas others require no or minimal treatment and die due to cause other tha...
Open access
Research Article
10.9734/jammr/2022/v34i631308